期刊文献+

阿司匹林抵抗与不稳定型心绞痛的临床研究 被引量:16

在线阅读 下载PDF
导出
摘要 目的:评估联合应用阿司匹林和氯吡格雷对阿司匹林抵抗的不稳定型心绞痛患者血小板聚集率的影响并随访半年的心血管事件(包括平均心绞痛发作的次数、急性心肌梗死、心血管性死亡、卒中发生率)。方法:选取临床诊断明确、病情稳定的阿司匹林抵抗不稳定型心绞痛患者40例。其中男26例,平均年龄为(56±8)岁;女14例,平均年龄(58±7)岁。分为治疗组和对照组,每组各20例。治疗组使用氯吡格雷75mg+阿司匹林100mg,每晚1次+常规治疗;对照组为阿司匹林100mg,每晚1次+常规治疗。结果:阿司匹林抵抗患者加用氯吡格雷后均可显著降低花生四烯酸、二磷酸酰酐诱导的血小板率(P<0.01);随访6个月心血管病事件情况显示联合应用氯吡格雷和阿司匹林可以明显减少阿司匹林抵抗组患者平均心绞痛发作的次数(144±21vs96±17,P<0.01),急性心肌梗死(20%vs5%,P<0.01)和卒中的发生率(25%vs5%,P<0.05)。结论:联合应用阿司匹林和氯吡格雷可以明显降低血小板聚集率,防止血栓形成,进而减少伴有阿司匹林抵抗不稳定型心绞痛患者心血管事件。
作者 吴常裕
出处 《实用医学杂志》 CAS 北大核心 2009年第13期2091-2092,共2页 The Journal of Practical Medicine
  • 相关文献

参考文献10

  • 1Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high-risk patients[J].BMJ,2002,324(7329):103-105.
  • 2Gum P A,Kottke-Marchant K,Welsh P A,et al.A prospective,blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease[J].J Am Coll Cardiol,2003,41 (6):961-965.
  • 3Antithrombotic Trialists' Collaboration[J].BMJ,2002,324(7329):71-86.
  • 4Eikelboom J W.Hznkev G J.Aspirin resistance:a new independent predictor of vascular events[J].J Am Coll Cardiol,2003,41 (11):966-968.
  • 5胡大一,孙艺红.正确认识阿司匹林“抵抗”[J].中华心血管病杂志,2006,34(12):1057-1058. 被引量:10
  • 6Gum P A,Kandice K M,Welsh P A,et al.A prospective,blinded determination of the natural history of aspirin resistance among stable patients with cardiovaacular disease[J].J Am Coll Cardiol,2003,41(6):961-965.
  • 7Weber A A,Zimmerman K C,Meyer-Kirchrath J,et al.Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance[J].Lancet,1999,353(9156):900.
  • 8Kawasaki T,Ozeki Y,Igawa T,et al.Increased platelet sensitivity to collgen in individuals resistant to low-dose aspirin[J].Stroke,2000,31(3):591-595.
  • 9Machi L,Christaens L,Brabant S,et al.Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphophate[J].Thromb Res,2002,107 (1-2):45-49.
  • 10Howard G,MeClure L A,KrakauerJ W,et al.Stroke and the statisties of the aspirin/clopidogrel secondary prevention trials[J].Curr Opin Neurol,2007,20(1):71-77.

二级参考文献9

  • 1ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.Randomised trial of intravenous streptokinase,oral aspirin,both,or neither among 17 187 cases of suspected acute myocardial infarction:ISIS-2.Lancet,1988,332:349-360.
  • 2Eikelboom JW,Hirsh J,Weitz JI,et al.Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction,stroke,or cardiovascular death in patients at high risk for cardiovascular events.Circulation,2002,105:1650-1655.
  • 3Zimmerman C,Kienzle P,Weber AA,et al.Aspirin resistance after coronary artery bypass grafting.J Thorac Cardiovasc Surg,2001,121:982-984.
  • 4Zimmermann N,Wenk A,Kim U,et al.Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.Circulation,2003,108:542-547.
  • 5Bhatt DL.Aspirin resistance:more than just a laboratory curiosity.J Am Coll Cardiol,2004,43:1127-1129.
  • 6Patrono C.Aspirin resistance:definition,mechanisms and clinical read-outs.J Thromb Haemos,2003,1:1710-1713.
  • 7Michelson AD.Platelet function testing in cardiovascular diseases.Circulation,2004,110:e489-493.
  • 8Wang TH,Bhatt DL,Topol EJ.Aspirin and clopidogrel resistance:an emerging clinical entity.Eur Heart J,2006,27:647-654.
  • 9Patti G,Colonna G,Pasceri V,et al.Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention.Results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) Study.Circulation,2005,111:2099-2106.

共引文献9

同被引文献87

引证文献16

二级引证文献123

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部